AVAH — Aveanna Healthcare Holdings Inc.

Aveanna Healthcare (AVAH) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: $622 million, a 22.2% increase year-over-year.
• Adjusted EBITDA: $80.1 million, a 67.5% increase from the previous year.
• Gross Margin: 32.6%, reflecting improved operational efficiencies.
• Private Duty Services (PDS) Revenue: Approximately $514 million, up 25.6%, driven by 11.8 million hours of care (12.9% volume increase).
• Home Health and Hospice Revenue: $62.4 million, a 15.3% increase, with 77% of admissions being episodic.
• Medical Solutions Revenue: $45.1 million, flat year-over-year, serving approximately 91,000 unique patients.
• Liquidity: $479 million, including $146 million cash on hand.

2. Strategic Updates and Business Highlights:

• Continued execution of a strategic transformation strategy focusing on aligning with preferred payers and government partners.
• Successful integration of Thrive Skilled Pediatrics, contributing to growth and expanding into Kansas and New Mexico.
• Achieved 30 preferred payer agreements in PDS, representing 56% of total MCO volumes.
• Legislative efforts resulted in 10 rate enhancements in private duty services.
• Focus on value-based care contracts, with 9 agreements in place, emphasizing fill rates and cost reduction.

3. Forward Guidance and Outlook:

• Revised 2025 revenue guidance to exceed $2.375 billion and adjusted EBITDA to exceed $300 million.
• Anticipated continued growth in preferred payer agreements, targeting mid- to high-30s in 2026.
• Expectation of ongoing improvements in caregiver hiring and retention, supporting capacity growth.

4. Bad News, Challenges, or Points of Concern:

• Labor market challenges persist, impacting caregiver recruitment and retention.
• General headwinds anticipated in state Medicaid funding due to budget constraints and the impact of the OBBBA legislation.
• Proposed cuts in the home health rule for 2026 could negatively affect reimbursement rates, with ongoing advocacy against these cuts.
• The Medical Solutions segment is still in the process of implementing a preferred payer strategy, which may take time to fully realize.

5. Notable Q&A Insights:

• Management expressed confidence in Q4 performance, indicating it should be similar to Q3 despite some seasonal challenges.
• There is cautious optimism regarding the sustainability of preferred payer relationships, with potential for growth in both existing and new markets.
• The company is focused on maintaining operational efficiencies and high-quality patient care, which they believe will position them favorably in the evolving healthcare landscape.
• Discussions highlighted the importance of legislative clarity regarding reimbursement rates, particularly for home health and hospice, before pursuing significant acquisitions in that space.

Overall, Aveanna demonstrated strong financial performance in Q3 2025, with strategic initiatives aimed at enhancing payer relationships and operational efficiencies, while also navigating challenges in labor markets and regulatory environments.